Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Medicenna Therapeutics Corp stock (MDNA)

Buy Medicenna Therapeutics Corp stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Medicenna Therapeutics Corp is a biotechnology business based in the US. Medicenna Therapeutics Corp shares (MDNA) are listed on the NASDAQ and all prices are listed in US Dollars. Medicenna Therapeutics Corp employs 16 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Medicenna Therapeutics Corp stock

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, and options with as little as $1
  • After-hours trading available
  • Earn 4.5% interest on uninvested cash with Gold
  • 24/7 customer support

Alternative pick for crypto trading

Go to site
  • $0 commission trading
  • Instant withdrawals with a 1.75% fee
  • Supports 250+ cryptocurrencies
  • High-yield account earns up to 4.65% APY
Terms apply. Cryptoassets are highly volatile. Your capital is at risk. Available in the US, CA, UK and AU

Disclaimer: This page is not financial advice or an endorsement of digital assets, providers or services. Digital assets are volatile and risky, and past performance is no guarantee of future results. Potential regulations or policies can affect their availability and services provided. Talk with a financial professional before making a decision. Finder or the author may own cryptocurrency discussed on this page.

How to buy Medicenna Therapeutics Corp stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – MDNA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Medicenna Therapeutics Corp stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Robinhood
Finder Score: 4.5 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
Uphold
Finder Score: 3.6 / 5: ★★★★★
Uphold
★★★★★
Cryptocurrency
N/A
$0
4.65%
Get $10
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Medicenna Therapeutics Corp stock price (NASDAQ: MDNA)

Use our graph to track the performance of MDNA stocks over time.

Medicenna Therapeutics Corp shares at a glance

Information last updated 2024-06-30.
52-week range$0.28 - $0.37
50-day moving average $0.29
200-day moving average $0.48
Wall St. target price$2.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.09

Is it a good time to buy Medicenna Therapeutics Corp stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Medicenna Therapeutics Corp financials

Gross profit TTM $0
Return on assets TTM -39.74%
Return on equity TTM -39%
Profit margin 0%
Book value $0.39
Market Capitalization $11.2 million

TTM: trailing 12 months

Medicenna Therapeutics Corp share dividends

We're not expecting Medicenna Therapeutics Corp to pay a dividend over the next 12 months.

Medicenna Therapeutics Corp share price volatility

Over the last 12 months, Medicenna Therapeutics Corp's shares have ranged in value from as little as $0.2839 up to $0.372. A popular way to gauge a stock's volatility is its "beta".

MDNA.US volatility(beta: 0.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Medicenna Therapeutics Corp's is 0.774. This would suggest that Medicenna Therapeutics Corp's shares are less volatile than average (for this exchange).

Medicenna Therapeutics Corp overview

Medicenna Therapeutics Corp. , an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops MDNA55, an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada. .

Frequently asked questions

What percentage of Medicenna Therapeutics Corp is owned by insiders or institutions?
Currently 23.651% of Medicenna Therapeutics Corp shares are held by insiders and 13.567% by institutions.
How many people work for Medicenna Therapeutics Corp?
Latest data suggests 16 work at Medicenna Therapeutics Corp.
When does the fiscal year end for Medicenna Therapeutics Corp?
Medicenna Therapeutics Corp's fiscal year ends in March.
Where is Medicenna Therapeutics Corp based?
Medicenna Therapeutics Corp's address is: 2 Bloor Street West, Toronto, ON, Canada, M4W 3E2
What is Medicenna Therapeutics Corp's ISIN number?
Medicenna Therapeutics Corp's international securities identification number is: CA58490H1073

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site